Skip to main content
Home
Loading...
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube

Menu top

  • Assistance

User account menu

  • Log in
Home

Main navigation

  • Home
  • Programme
Menu Login
Close

Main navigation mobile

  • Home
  • Programme

Menu top

  • Assistance
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
Filters
Filters Close
Poster topics
  • Aerobiology and pollution (41)
  • Allergen immunotherapy (81)
  • AllergoOncology (15)
  • Allergy asthma and a sport (4)
  • Allergy diagnosis (235)
  • Allied health and primary care (20)
  • Anaphylaxis (113)
  • x Artificial Intelligence (12)
  • Asthma (185)
  • Basic immunology (58)
  • Biologicals (90)
  • Biomarkers (64)
  • Comparative veterinary allergology (1)
  • COVID19 (11)
  • Dermatology (125)
  • x Drug allergy (172)
  • ENT (29)
  • Environmental allergy and climate change (31)
  • Eosinophilic esophagitis (21)
  • Epidemiology (66)
  • Epithelial cell biology (8)
  • Food allergy (195)
  • Genomics and proteomics (17)
  • Immune deficiencies and autoimmunity (80)
  • Immunomodulation and nutrition (13)
  • Infections (27)
  • Insect venom hypersensitivities (19)
  • Mastocytosis and mast cells (24)
  • Microbiome (9)
  • Occupational allergy (27)
  • Ocular allergy (5)
  • One Health (13)
  • Pediatrics (144)
  • Prevention (40)
  • Systems medicine (13)
Poster available until
  • Until platform closure (20)
Poster categories
  • e-Thematic Poster Session (15)
  • Thematic Poster Session (155)
keywords
Session Reference
  • L-TPS01 (6)
  • L-TPS02 (1)
  • L-TPS05 (12)
  • L-TPS07 (1)
  • L-TPS09 (1)
  • L-TPS12 (11)
  • L-TPS13 (4)
  • L-TPS14 (6)
  • L-TPS15 (2)
  • L-TPS18 (1)
  • TPS02 (1)
  • TPS03 (3)
  • TPS05 (1)
  • TPS08 (1)
  • TPS11 (13)
  • TPS12 (12)
  • TPS14 (2)
  • TPS25 (1)
  • TPS28 (3)
  • TPS31 (3)
  • TPS36 (12)
  • TPS37 (3)
  • TPS38 (6)
  • TPS52 (5)
  • TPS53 (6)
  • TPS54 (15)
  • TPS55 (3)
  • TPS57 (1)
  • TPS61 (11)
  • TPS62 (9)
  • TPS63 (7)
  • TPS67 (1)
  • TPS69 (2)
  • TPS73 (3)
184 results
Thumbnail

D1.233 - Pembrolizumab IgE mediated drug hypersensitivity reaction and successful desensitisation

Thumbnail

D1.234 - The Importance of Differential Diagnosis in DRESS Syndrome: Review of 2 Cases

Thumbnail

D1.235 - Clorhexidine allergy in northern area of Seville

Thumbnail

D1.236 - Clinical Outcomes of Neuromuscular Blocking Agent Rechallenge Based on Skin Prick Test in Patients with Intraoperative Anaphylaxis

Thumbnail

D1.237 - What Do Drug Skin Tests Tell Us About Quinolone Allergy? Adult Allergy Reference Center Experience

Thumbnail

D1.238 - Urgent desensitization to amiodarone

Thumbnail

D1.239 - Nonsteroidal anti-inflammatory drug cross-hypersensitivity phenotypes show high carbonyl levels

Thumbnail

D1.243 - L-asparaginase desensitization in children

Thumbnail

D1.244 - Retrospective Analysis of Adverse Reactions to Iodinated Contrast Media: Experience in 165 Patients

Thumbnail

D1.245 - Platinum salt hypersensitivity: Experience of our Center

Thumbnail

D1.246 - Cephalosporin Allergy in Children

Thumbnail

D1.247 - Tolerance to intravenous sodium heparin despite a positive subcutaneous challenge test: A case report

Thumbnail

D1.383 - Nonimmediate hypersensitivity reaction to Lanadelumab in a patient with Hereditary Angioedema: a case report

Thumbnail

D1.75 - Anaphylaxis during Picc Line replacement

Thumbnail

D1.77 - Perioperative Hypersensitivity Outcomes: A retrospective review of 112 patients seen between 2019 and 2024 at two allergy centres

Thumbnail

D1.82 - Diagnostic challenges in amoxicillin-clavulanate anaphylaxis: an inconclusive in vitro study – Case Report

Thumbnail

D1.84 - IgE-mediated allergy to chlorhexidine: case report

Thumbnail

D1.85 - Basophil activation test in β-Lactam Anaphylaxis: A Case Series from a Tertiary Hospital

Thumbnail

D1.86 - Hypersensitivity Reaction to Lugol’s Solution: A Case Report

Thumbnail

D2.115 - Association of chemokine levels with types of reactions after alcohol consumption in patients with nonsteroidal anti-inflammatory drugs exacerbated respiratory disease (N-ERD)

Pagination

  • First page First
  • Previous page Previous
  • Page 1
  • Page 2
  • Current page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next
  • Last page Last
Download the app
The congress at your fingertips

Available on

App Store Google Play
QR Code Download
Mobile App Schedule page
Mobile App Home page
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
© 2025 EAACI
Made with   by CYIM